首页> 外文期刊>Immunologic Research: A Selective Reference to Current Research and Practice >Highlighting the problematic reliance on CD18 for diagnosing leukocyte adhesion deficiency type 1
【24h】

Highlighting the problematic reliance on CD18 for diagnosing leukocyte adhesion deficiency type 1

机译:突出了对CD18诊断白细胞粘附缺乏症1型所依赖的问题

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Leukocyte adhesion deficiency type 1 (LAD-1) is an autosomal recessive primary immunodeficiency, hallmarked by defective polymorphonuclear transmigration. It is caused by mutations in the gene encoding CD18, which interfere with the CD18/CD11 heterodimerization and expression on leukocyte cell surface. LAD-1 diagnosis rests primarily on the measurement of CD18 expression. However, CD18 measurement entails its pitfalls. Here we present a cohort of ten LAD patients and a review of the relevant literature illustrating the difficulties in sole reliance on CD18 measurement for initial diagnosis. These include normal range expression in some mutations, great variability between patients with the same mutation and subjective interpretation of results. We think there is a need for additional markers as part of the initial LAD diagnostic algorithm. We suggest CD11a expression, which was near absent in all patients in our cohort. The dual use of CD18 and CD11a can increase testing sensitivity and prevent delayed diagnosis of LAD-1.
机译:白细胞黏附缺乏症1型(LAD-1)是常染色体隐性原发性免疫缺陷,以多形核转运缺陷为特征。它是由编码CD18的基因突变引起的,该突变会干扰CD18 / CD11异源二聚化和白细胞表面的表达。 LAD-1诊断主要取决于CD18表达的测量。但是,CD18的测量存在陷阱。在这里,我们介绍了一组10名LAD患者,并回顾了相关文献,阐明了仅依靠CD18测量进行初步诊断存在的困难。这些包括某些突变的正常范围表达,具有相同突变的患者之间的巨大差异以及对结果的主观解释。我们认为有必要将其他标记作为初始LAD诊断算法的一部分。我们建议CD11a表达,在我们队列中的所有患者中几乎都不存在。 CD18和CD11a的双重使用可以提高测试灵敏度并防止LAD-1的延迟诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号